ADCT
Price
$3.53
Change
+$0.03 (+0.86%)
Updated
Dec 24 closing price
Capitalization
437.29M
76 days until earnings call
Intraday BUY SELL Signals
IMTX
Price
$10.37
Change
+$0.15 (+1.47%)
Updated
Dec 24 closing price
Capitalization
1.39B
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ADCT vs IMTX

Header iconADCT vs IMTX Comparison
Open Charts ADCT vs IMTXBanner chart's image
ADC Therapeutics SA
Price$3.53
Change+$0.03 (+0.86%)
Volume$392.47K
Capitalization437.29M
Immatics
Price$10.37
Change+$0.15 (+1.47%)
Volume$150.96K
Capitalization1.39B
ADCT vs IMTX Comparison Chart in %
ADCT
Daily Signal:
Gain/Loss:
IMTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ADCT vs. IMTX commentary
Dec 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADCT is a Hold and IMTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 26, 2025
Stock price -- (ADCT: $3.53 vs. IMTX: $10.37)
Brand notoriety: ADCT and IMTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADCT: 31% vs. IMTX: 25%
Market capitalization -- ADCT: $437.29M vs. IMTX: $1.39B
ADCT [@Biotechnology] is valued at $437.29M. IMTX’s [@Biotechnology] market capitalization is $1.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADCT’s FA Score shows that 1 FA rating(s) are green whileIMTX’s FA Score has 0 green FA rating(s).

  • ADCT’s FA Score: 1 green, 4 red.
  • IMTX’s FA Score: 0 green, 5 red.
According to our system of comparison, ADCT is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADCT’s TA Score shows that 4 TA indicator(s) are bullish while IMTX’s TA Score has 4 bullish TA indicator(s).

  • ADCT’s TA Score: 4 bullish, 6 bearish.
  • IMTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than ADCT.

Price Growth

ADCT (@Biotechnology) experienced а -3.81% price change this week, while IMTX (@Biotechnology) price change was +4.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

ADCT is expected to report earnings on Mar 12, 2026.

IMTX is expected to report earnings on Mar 25, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.39B) has a higher market cap than ADCT($437M). ADCT YTD gains are higher at: 77.387 vs. IMTX (45.851). IMTX has higher annual earnings (EBITDA): -106.34M vs. ADCT (-112.75M). IMTX has more cash in the bank: 431M vs. ADCT (235M). IMTX has less debt than ADCT: IMTX (16.4M) vs ADCT (117M). IMTX has higher revenues than ADCT: IMTX (84.8M) vs ADCT (75.2M).
ADCTIMTXADCT / IMTX
Capitalization437M1.39B31%
EBITDA-112.75M-106.34M106%
Gain YTD77.38745.851169%
P/E RatioN/A27.61-
Revenue75.2M84.8M89%
Total Cash235M431M55%
Total Debt117M16.4M713%
FUNDAMENTALS RATINGS
IMTX: Fundamental Ratings
IMTX
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
98
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
63
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADCTIMTX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ADCT
Daily Signal:
Gain/Loss:
IMTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSFIX25.550.10
+0.39%
Federated Hermes MDT Small Cap Value IS
FVILX6.120.02
+0.33%
Forester Value I
JHDAX20.040.05
+0.25%
JPMorgan Hedged Equity 2 A
MNNYX69.580.10
+0.14%
Victory Multi-Cap Y
RAPCX11.060.01
+0.09%
Cohen & Steers Real Assets C

ADCT and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADCT has been loosely correlated with CLRB. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ADCT jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADCT
1D Price
Change %
ADCT100%
+0.86%
CLRB - ADCT
41%
Loosely correlated
+2.60%
QTTB - ADCT
41%
Loosely correlated
+2.56%
NUVL - ADCT
40%
Loosely correlated
+0.89%
RGNX - ADCT
39%
Loosely correlated
+0.77%
IMTX - ADCT
37%
Loosely correlated
+1.47%
More

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+1.47%
IDYA - IMTX
54%
Loosely correlated
+0.76%
CGON - IMTX
51%
Loosely correlated
+0.22%
VYGR - IMTX
50%
Loosely correlated
+2.01%
SYRE - IMTX
49%
Loosely correlated
-0.54%
CRNX - IMTX
48%
Loosely correlated
-0.33%
More